Skip to content

Library study of kidney stone dissolving medicaments in Persian medicine and evaluation of a related multi-ingredient formulation in dissolving calcium kidneystones; a double-blind randomized clinical trial

Library study of kidney stone dissolving medicaments in Persian medicine and evaluation of a related multi-ingredient formulation in dissolving calcium kidneystones; a double-blind randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191212045709N1
Enrollment
60
Registered
2020-09-29
Start date
2020-01-15
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal stone.

Interventions

The intervention group consumes 2 capsules (one in the morning and one at night) of freeze dried water extract of 6 plants including: Tribulus terrestris-Foeniculum vulgare-Pimpinella anisum- Cucumis

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18 years and older Calcium kidney stones with a size of 5 mm or more based on imaging results Lack of confirmed history of acute renal failure Lack of confirmed history of chronic kidney disease having no present urinary tract infection no concurrent use of medications including:®Sankol? ®Rowatinex and Cystone® no pregnancy or breast feeding

Exclusion criteria

Exclusion criteria: Age 18 years and older Calcium kidney stones with a size of 5 mm or more based on imaging results Lack of confirmed history of acute renal failure Lack of confirmed history of chronic kidney disease having no present urinary tract infection no concurrent use of medications including:®Sankol? ®Rowatinex and Cystone® no pregnancy or breast feeding

Design outcomes

Primary

MeasureTime frame
Liver function test- renal function test-Ca and P serum level, urine analysis, 24 hour urine volume and stone diameter. Timepoint: At the beginning of the study and one month after the end of the course of medication. Method of measurement: KUB- URINE ANALYSIS-BLOOD ANALYSIS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMM ZARSHENAS

Shiraz University of Medical Sciences

ZARM@SUMS.AC.IR+98 917 711 3491

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026